Myelodysplastic syndromes and systemic manifestations. A non-casual association;Myélodysplasies et maladies systémiques. Une association non fortuite

Revue de Medecine Interne

Volumn 22, Issue 5, 2001, Pages 428-432

  Berthier, S ^a   Magy, N ^a   Gil, H ^a   Becker Schneider, M ^a   Vuitton, D A ^a   Dupond, J L ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Elderly; Myelodysplastic syndrome; Systemic manifestations

Indexed keywords

COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; MELPHALAN;

AGED; AMYLOIDOSIS; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; ONSET AGE; POLYARTHRITIS; PYODERMA GANGRENOSUM; REFRACTORY ANEMIA; RELAPSING POLYCHONDRITIS; RETROSPECTIVE STUDY; SIDEROBLASTIC ANEMIA; SYSTEMIC DISEASE; VASCULITIS;

EID: 0343844251     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(01)00367-8     Document Type: Article

References (25)

1. Pautas E., Gaillard M., Chambon-Pautas C., Siguret V., Andreux J.P., Gaussem P. Les syndromes myélodysplasiques. Diagnostic et prise en charge des patients de plus de 70 ans. Presse Méd. 28:1999;1771-1778.
2. Bauduer F., Ducout L., Dastugue N., Capdupuy C., Renoux M. Epidemiology of myelodysplastic syndromes in a French general hospital of the Basque country. Leuk Res. 22:1998;205-208.
3. Nisse C. Facteurs étiologiques des syndromes myélodysplasiques. Pathol Biol. 45:1997;539-544.
4. Blanco R., Gonzales Gay M.A., Ibanez D., Lopez-Vianna A., Ferran C., et al. Henoch-Schonlein purpura as clinical presentation of a myelodysplastic syndrome. Clin Rheumatol. 16:1997;626-628.
5. Maeda Y., Arakawa K., Araki E., Kikuchi H., Ikezoe K., Taniwaki T., et al. Polymyositis and cutaneous vasculitis in a patient with myelodysplastic syndrome. Rinsho Shinkeigaku. 39:1999;639-642.
6. Brickner L.A., Scannell K.A. Medium vessel PAN type vasculitis associated with myelodysplastic syndrome and presenting as bilateral perinephric hematomas. Clin Exp Rheumatol. 15:1997;221-225.
7. Piette J.C., Papo T., Chavanon P., Le Thi Huong D., Frances C., Godeau P. Myelodysplasia and relapsing polychondritis. J Rheumatol. 22:1995;1208-1208.
8. Hebbar M., Brouillard M., Wattel E., Decoulx M., Hatron P.Y., Devulder B., et al. Association of myelodysplastic syndrome and relapsing polychondritis : further evidence. Leukemia. 9:1995;731-733.
9. Enright H., Jacob H.S., Vercelotti G., Howe R., Belzer M., Miller W. Autoimmune phenomena in myelodysplastic syndromes : response to immunosuppressive therapy. Leukemia Res. 18 Suppl:1994;54-54.
10. George S.W., Newman E.D. Seronegative inflammatory arthritis in the myelodysplastic syndromes. Semin Arthritis Rheum. 21:1992;345-354.
11. Weber R.F.A., Geraedts J.P.M., Kerkhofs H., Leeksma C.H. The preleukemic syndrome. Acta Med Scand. 207:1980;391-395.
12. Nakayama S., Ishikawa T., Yabe H., Nagai K. Refractory anemia complicated by Behçet disease. A report of three cases. Rinsho Ketsueki. 30:1989;530-534.
13. Eng C., Farraye F.A., Shulman L.N., Peppercom M.A., Krauss C.M., Connors J.M. The association between the myelodysplastic syndromes and the Crohn disease. Ann Intern M. 117:1992;661-662.
14. Pirayesh A., Verbunt R.J.A.M., Kluin P.M., Meinders A.E., De Meijer P.H.E.M. Myelodysplastic syndrome with vasculitic manifestations. J Intern M. 242:1997;425-431.
15. Castro M., Conn D.L., Su D., Garton J.P. Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol. 18:1991;721-727.
16. Okamoto T., Okada M., Mori A., Saheki K., Takatsuka H., Wada H., et al. Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients. Int J Hematol. 66:1997;345-351.
17. Hebbar M., Hebbar Savéan K., Fenaux P. Maladies systémiques au cours des syndromes myélodysplasiques. Rev Méd Interne. 16:1995;897-904.
18. Kuzmich P.V., Ecker G.A., Karsh J. Rheumatic manifestations in patients with myelodysplastic and myeloproliferative diseases. J Rheumatol. 21:1994;1649-1654.
19. Hebbar M., Kozlowski D., Wattel E., Mastrini S., Dievart M., Duclos B., et al. Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature. Leukemia. 11:1997;2188-2191.
20. Harewood G.C., Loftus E.V. Jr, Tefferi A., Tremaine W.J., Sandborn W.J. Concurrent inflammatory bowel disease and myelodysplastic syndromes. Inflammatory Bowel Dis. 5:1999;98-103.
21. Savige J.A., Chang L., Smith C.L., Duggan J.C. Myelodysplasia vasculitis and anti-neutrophil cytoplasm antibodies. Leukemia Lymphoma. 9:1993;49-54.
22. McCarty C.J., Sheldon S., Ross C.W., McCune W.J. Cytogenetic abnormalities and therapy-related myelodysplastic syndromes in rheumatic disease. Arthritis Rheum. 41:1998;1493-1496.
23. Reinhold-Keller E., Beuge N., Latza U., De Groot K., Rudert H., Nölle B., et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis. Arthritis Rheum. 43:2000;1021-1032.
24. Hamblin T.J. Immunological abnormalities in myelodysplastic syndromes. Semin Hematol. 33:1996;150-162.
25. Fenaux P. Myelodysplastic syndromes. Hematol Cell Ther. 38:1996;89-93.